Anzeige
Meldung des Tages: Gold im Fokus: Warum diese milliardenschwere Goldaktie vom aktuellen Goldumfeld profitieren könnte

Laboratory of America Aktie News

Aktie
WKN:  A40C39 ISIN:  US5049221055 US-Symbol:  LH Land:  USA
234,00 €
+0,00 €
0,00%
17:33:12 Uhr
Depot/Watchlist
Marktkapitalisierung *
18,05 Mrd. €
Streubesitz
1,60%
KGV
15,50
Dividende
2,88 $
Dividendenrendite
1,15%
neu: Nachhaltigkeits-Score
49 %
Index-Zuordnung
S&P 500

Laboratory of America News

24.09.24 - PR Newswire
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
Labcorp to Announce Third Quarter Financial Results on October 24, 2024 PR Newswire
18.09.24 - PR Newswire
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience PR Newswire
16.09.24 - PR Newswire
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE ...
16.09.24 - PR Newswire
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health PR Newswire
03.09.24 - PR Newswire
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
Labcorp to Speak at the Baird 2024 Global Healthcare Conference PR Newswire
05.08.24 - PR Newswire
Labcorp Finalizes Acquisition of Select Assets of Invitae
Labcorp Finalizes Acquisition of Select Assets of Invitae PR Newswire
02.08.24 - PR Newswire
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx PR Newswire
01.08.24 - PR Newswire
Labcorp Announces 2024 Second Quarter Results
Labcorp Announces 2024 Second Quarter Results PR Newswire
30.07.24 - PR Newswire
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities PR Newswire
25.07.24 - PR Newswire
Labcorp Declares Quarterly Dividend
Labcorp Declares Quarterly Dividend PR Newswire
01.07.24 - PR Newswire
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
Labcorp to Announce Second Quarter Financial Results on August 1, 2024 PR Newswire
17.06.24 - PR Newswire
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials PR Newswire
03.06.24 - PR Newswire
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio PR Newswire
30.05.24 - PR Newswire
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting PR Newswire
28.05.24 - PR Newswire
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference PR Newswire
15.05.24 - PR Newswire
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy PR Newswire
08.05.24 - PR Newswire
Labcorp to Webcast Its Annual Meeting of Shareholders
Labcorp to Webcast Its Annual Meeting of Shareholders PR Newswire
07.05.24 - PR Newswire
Invitae Receives Court Approval for Sale to Labcorp
Invitae Receives Court Approval for Sale to Labcorp PR Newswire
29.04.24 - PR Newswire
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B PR Newswire
25.04.24 - PR Newswire
Labcorp Announces 2024 First Quarter Results
Labcorp Announces 2024 First Quarter Results PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +9,48%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »